Unveiling the efficacy predictors and potential mechanisms of Semen Cuscutae against osteoporosis via machine learning and meta-analysis: a preclinical study

• by Bo Dong, Rui Tang, Dongping Wan, Haoxiang Yuan, Chuan Leng, Rui Wang, Feilong Li, Junbo He, Yong Peng, Shihang Cao, Baohui Wang

• June 10, 2026

Editorial: Vibratory therapy: impacts on endocrine disorders

• by Mario Bernardo-Filho, Francois Constant Boyer, Redha Taiar, Danúbia da Cunha de Sá-Caputo

• June 1, 2026

Development and validation of a multimodal interpretable machine learning model for the identification of osteoporosis in patients with type 2 diabetes mellitus: a multicenter retrospective study

• by Jihao Cheng, Chuanjiang Liu, Mengyin Gu, Dongying Su, Jingyun Liao

• July 1, 2026

OI Therapy Raised BMD, Not Fracture Benefit

Teriparatide followed by zoledronic acid increased bone mineral density but did not reduce fracture risk compared with standard care in adults with osteogenesis imperfecta.

• by Andrea Surnit

• June 5, 2026

• 7 min